-
Mashup Score: 1myelocast - 8 month(s) ago
A new Flutter project.
Source: eatoure.github.ioCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Mortality in the US Populations With MGUS - 9 month(s) ago
This cohort study analyzes a nationally representative sample with a screening test for monoclonal gammopathy of undetermined significance (MGUS) to evaluate overall survival of populations with MGUS compared with those without MGUS among the general population in the US.
Source: jamanetwork.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 22How to Treat MGUS and Smoldering Myeloma with Dr. S. Vincent Rajkumar – ONC Brothers - 9 month(s) ago
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…
Source: oncbrothers.comCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Tool Using Time-Varying Biomarkers Predicts the Risk of Progression from Precursor Disease to MM | ASH Clinical News | American Society of Hematology - 10 month(s) ago
Skip Nav Destination May 9, 2023 Anna Azvolinsky, PhD, is a freelance medical and science journalist based in New York City. For patients with precursor disease to multiple myeloma (MM), the standard for predicting disease…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0IBC – Intercepting Blood Cancers - 1 year(s) ago
We are preparing a warm welcome in Madrid for the 2023 Intercepting Blood Cancers Meeting (IBC 2023). Taking place from 3-5 March 2023, the IBC 2023 Hybrid Meeting will provide a unique, interactive platform for presentations on key clinical trial data and expert clinical insights for early interventions in blood cancers and how this impacts outcomes for patients; three key topic tracks will…
Source: ibc2023.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 4Understanding MGUS & Smoldering Myeloma: What’s the Difference? - Patient Empowerment Network - 1 year(s) ago
Dr. Irene Ghobrial explains the difference between MGUS and smoldering myeloma, including how these conditions are detected.
Source: Patient Empowerment NetworkCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1
Dr. Mark Schroeder defines the difference between smoldering myeloma and MGUS, and discusses how asymptomatic myeloma is monitored.
Source: Patient Empowerment NetworkCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men - 1 year(s) ago
AbstractBackground:. Both multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance (MGUS), occur twice as often within Black compared with White populations, suggesting that racial disparities lie within the development of MGUS. Nonetheless, MGUS has been studied mainly in White cohorts; the study that first described the natural history of MGUS was conducted in…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Prevalence of Monoclonal Gammopathy of Undetermined Significance in Black South African Men - 1 year(s) ago
AbstractBackground:. Both multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance (MGUS), occur twice as often within Black compared with White populations, suggesting that racial disparities lie within the development of MGUS. Nonetheless, MGUS has been studied mainly in White cohorts; the study that first described the natural history of MGUS was conducted in…
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Paper: Transient M-Proteins: Epidemiology, Causes, and the Impact of Mass Spectrometry: The Istopmm Study - 1 year(s) ago
Oral and Poster Abstracts Oral 652. Multiple Myeloma and Plasma Cell Dyscrasias: Clinical and Epidemiological: Disease Monitoring Plasma Cell Disorders, Diseases, Lymphoid Malignancies Robert Palmason1,2,3*, Oscar Berlanga, PhD4*, Jon Kristinn Sigurdsson1*, Sæmundur Rögnvaldsson, MD5,6*, Sigrun Thorsteinsdottir, MD, PhD1,7, Sara Ekberg, PhD8*, Michael Crowther, PhD8*, Marina…
Source: ash.confex.comCategories: Hem/Oncs, Latest HeadlinesTweet
RT @rexprem: If you want to estimate risk of progression in #myeloma, #SMM and #MGUS. Please visit https://t.co/gdgK0qwI2Q. Amazing work by…